Ion Beam Applications SA (OTCMKTS:IOBCF) Sees Significant Increase in Short Interest

Ion Beam Applications SA (OTCMKTS:IOBCF) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 680 shares, an increase of 53.8% from the December 15th total of 442 shares. Based on an average daily volume of 164 shares, the short-interest ratio is currently 4.1 days. Based on an average daily volume of 164 shares, the short-interest ratio is currently 4.1 days.

Ion Beam Applications Stock Performance

OTCMKTS IOBCF traded up $0.86 during trading hours on Friday, hitting $16.06. 100 shares of the company’s stock were exchanged, compared to its average volume of 667. Ion Beam Applications has a 12-month low of $10.15 and a 12-month high of $16.15. The business’s 50 day moving average is $14.79 and its 200-day moving average is $13.91.

Ion Beam Applications Company Profile

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.